You just read:

OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers

News provided by

OncoSec Medical Incorporated

Jun 27, 2019, 08:30 ET